ArticleCardiovascular drugs and therapy2023

Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD).

Shipra Bhansali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.